Thank you, Mr. Chair.
As Minister Hajdu indicated, we have a strong regulatory organization here and have significantly increased capacity for the reviews of vaccine candidates. We do co-operate internationally on a multilateral basis through the International Coalition of Medicines Regulatory Authorities, which has focused on vaccines and therapeutics associated with COVID. We have also worked closely with a number of trusted regulatory partners, including the U.S. Food and Drug Administration, the European Medicines Agency, the United Kingdom, Switzerland and Australia.
That work continues to enable us to learn from each other and have additional support and scientific evaluation to help us ensure that we have strong reviews and expedite the process.